Publications by authors named "Rachel Tetaz"

Claim this Profile
A
Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies.
Quentin Perrier, Johan Noble, Steven Grangé, Pierrick Bedouch, Rachel Tetaz

Case Rep Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Pneumonia under Belatacept and Everolimus: Benefit-Risk Balance between Renal Allograft Function and Infection.
Quentin Perrier, Antoine Portais, Florian Terrec, Yann Cerba, Thierry Romanet, Rachel Tetaz

Case Rep Nephrol Dial· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predonation Single Kidney Glomerular Filtration Rate in Living Kidney Transplantation to Predict Graft Function and Donor Functional Gain.
Morgane Heitz, Thomas Jouve, Matthieu Roustit, Nicolas Terrier, Gaëlle Fiard, Rachel Tetaz

Transplant Proc· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The contribution of an ethical concertation group in nephrology validated by a research protocol].
Jocelyne Maurizi-Balzan, Éric Fourneret, Laurence Cimar, Johan Noble, Hamza Naciri-Bennani, Rachel Tetaz

Nephrol Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Prediction of Graft Outcomes After Kidney Transplantation From Donors After Circulatory Death: Biomarkers and Transplantation Characteristics.
Anne-Sophie Truche, Candice Trocme, Sabrina Vergnaud, Bénédicte Janbon, Diane Giovannini, Rachel Tetaz

Transplant Proc· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case Series.
Hamza Naciri Bennani, Thomas Jouve, Johan Noble, Lionel Rostaing, Paolo Malvezzi, Rachel Tetaz

Case Rep Nephrol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Screening Using Luminex for De Novo C3d Fixing of Class II Donor-Specific Antibodies Is Correlated With Luminex Mean Fluorescence Intensity in Renal Transplant Patients.
Morgane Villemaire, Thomas Jouve, Anne Bourdin, Bénédicte Janbon, Nicole Pinel, Rachel Tetaz

Exp Clin Transplant· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe acute hepatitis after thymoglobulin induction before islet transplantation.
Quentin Perrier, Rachel Tetaz, Magalie Baudrant, Marion Lepelley, Thierry Berney

Therapie· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.
Sandrine Lablanche, Marie-Christine Vantyghem, Laurence Kessler, Anne Wojtusciszyn, Sophie Borot, Rachel Tetaz

Lancet Diabetes Endocrinol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aortic bypass surgery for asymptomatic patients awaiting a kidney transplant: A word of caution.
Quentin Franquet, Nicolas Terrier, Augustin Pirvu, Jean-Jacques Rambeaud, Jean-Alexandre Long, Rachel Tetaz

Clin Transplant· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network.
Sandrine Lablanche, Sophie Borot, Anne Wojtusciszyn, Francois Bayle, Rachel Tétaz

Diabetes Care· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor-specific antibodies.
Laure-Emmanuelle Croze, Rachel Tetaz, Matthieu Roustit, Paolo Malvezzi, Bénédicte Janbon

Transpl Int· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive diagnostic of chronic allograft dysfunction using urinary proteomics analysis.
Rachel Tetaz, Candice Trocmé, Mathieu Roustit, Nicole Pinel, François Bayle

Ann Transplant· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICT.
Sebastien Dharancy, Magali Giral, Rachel Tetaz, Michel Fatras, Laurence Dubel

Clin Transplant· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: a randomized, open-label multicenter study.
Laetitia Albano, Eric Alamartine, Olivier Toupance, Bruno Moulin, Pierre Merville, Rachel Tetaz

Ann Transplant· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis